Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02823626 · ClinicalTrials.gov registry record
High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure
A clinical trial, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 48
- Enrollment target
NCT02823626 is a clinical trial that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 48 participants.
The verdict
NCT02823626 has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
Primary Aims 1. Evaluate the safety of high-dose spironolactone in combination of patiromer in acute decompensated heart failure patients. 2. Evaluate the efficacy of high-dose spironolactone in combination of patiromer in causing volume loss and symptom relief in patients with ADHF treated with high-dose spironolactone. Secondary Aims 1: Evaluate the effect of high-dose spironolactone on urinary sodium excretion and renal function.
Interventions
- DRUG Spironolactone and patiromer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02823626
The ClinicalTrials.gov registry entry for NCT02823626 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Spironolactone and patiromer is the first listed.
NCT02823626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02823626 about?
NCT02823626 is a clinical study titled "High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure". Primary Aims 1. Evaluate the safety of high-dose spironolactone in combination of patiromer in acute decompensated heart failure patients. 2. Evaluate the efficacy of high-dose spironolactone in combination of patiromer in causing volume loss and symptom relief in patients with ADHF treated with hi...
What is the current status of trial NCT02823626?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2016-09. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02823626?
The interventions under investigation include: Spironolactone and patiromer (DRUG).
Who is sponsoring clinical trial NCT02823626?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.